EVEN at its scientific best, the practice of medicine relies on the assumption that generalized notions of diseases and their detection and treatment can be individualized. Thus, large multicenter studies are interpreted as providing meaningful guidelines for treating a single patient; we assume that the patient will respond in a manner similar to the majority of the study group. The usefulness of such assumptions is limited, of course, but in daily practice physicians have no better basis for management decisions other than what is in the literature. This is especially true in rapidly changing, technologically oriented specialties such as cardiology.
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Gender is one of the most obvious ways in which an individual patient may differ from the population presented in the literature. We readily accept that diseases may have different prevalences in men and women and even that disease processes may differ as well. However, it is not often appreciated that the interpretation of diagnostic tests or the successful application of therapeutic modalities may depend on the patient's sex.
Given the epidemiology of most forms of heart disease, it is not surprising that most of the descriptions of cardiac diagnostic testing, risk factors for disease, and even expected therapeutic outcomes are determined largely, if not exclusively, by studies of male patients. Because relatively fewer women are studied, any possible differences between the sexes may be overlooked. For example, of the three most cited studies examining the role of coronary artery bypass grafting in atherosclerotic coronary artery disease, the Veterans Administration Cooperative Study1 and the European Coronary Surgery Study2 included only men, while the population of the Coronary Artery Surgery Study (CASS) was only 19% female.3 Yet the results of these studies are used daily to justify coronary surgery in women. If the outcomes in both sexes were similar, the composition of the study populations would not matter. However, the CASS study found that the operative From the Cardiovascular Section, Hospital of the University of Pennsylvania, Philadelphia. mortality for women was 2.7 times greater than that for men, despite the presence of less severe coronary disease and better ventricular function in women.3 Because the superiority of surgical treatment for certain types of coronary artery disease depends on small dif ferences in long-term survival between patients receiving medical treatment and those receiving surgical treatment, the excess operative mortality in women could be enough to tip the balance toward medical therapy when making clinical decisions for an individual female patient. However, the CASS study has not directly compared medical and surgical outcome in women.3 Furthermore, the high mortality in the female subgroup may cause misleading overall results, thereby predicting a poorer outcome in men than is actually the case. The clinician deciding whether or not to recommend surgery for a female patient is forced to use data that either do not apply or are at best incomplete in comparison with those available for decision making in a male patient.
Documenting differences between the sexes can provide valuable information about the pathophysiology of diseases. As scientists, we should ask why such differences occur and what can be learned about both the male and female response by examining them. In the example above, while attempting to understand the sex-related difference in operative mortality, CASS investigators examined the effects of size of the coronary artery on outcome. Their results showed that women had coronary arteries of smaller diameters, and that this was closely related to mortality. Even more important, they then analyzed the relationship between coronary size and outcome in men and found that coronary diameter was a significant predictive variable in both sexes.4 This is clearly an important piece of information, not just for women, but also for men. Thus, individuals of both sexes benefit from an enhanced knowledge of the determinants of surgical outcome. This advantage might have been lost if the data were not examined first for differences between the sexes and then for possible explanations. Perhaps preexisting data banks should be reexamined with special reference to differences in male and female responses and the origins of such differences.
There are a number of other instances in which the female and male pathophysiology are known to differ. Since, at least in heart disease, the male pattern of response is more widely studied and therefore more generally accepted as "normal," the female pattern, when different, is more likely to be labeled "abnormal" or at least atypical, often leading to the suspicion of heart disease in its absence (false-positive test results). Examples of this that are known to occur in cardiac diagnostic testing are discussed below.
Measurement of exercise ejection fraction is commonly used to evaluate cardiac reserve, with the normal response thought to be an exercise-related increase of at least 5%. However, in a study of age-matched volunteers, ejection fractions increased with exercise in males but not in females. 5 These results suggest that women would have a higher likelihood of false-positive diagnoses of abnormal exercise response especially if, as is the case, the male response is taken to be normal for both sexes. These differences may provide an explanation for the "abnormal" cardiac exercise response described in patients with mitral valve prolapse (MVP). One study,6 finding that in some patients with MVP there was no augmentation of ejection fraction with exercise, suggested that a "cardiomyopathic process" might be present that was "obvious only during exercise." However, given the knowledge that the ejection fraction normally does not increase in women with exercise, and that patients with MVP are predominantly female, the authors may simply be documenting this normal female response to exercise rather than providing evidence of left ventricular dysfunction. An additional important difference has also been noted in the mechanisms by which stroke volume is increased in men and women during exercise.5 In women end-diastolic but not end-systolic left ventricular size is increased, so that increased preload is relied upon to augment cardiac output. In men end-systolic size decreases while end-diastolic size is unchanged, so an increase in stroke volume is achieved by increased shortening. Certainly these gender-related differences in exercise response are intriguing, and their investigation may eventually cast light on the male as well as the female exercise response.
The most widely used diagnostic test for coronary artery disease is electrocardiographic monitoring during treadmill exercise testing. The incidence of falsepositive exercise tests is far higher in women than in men, and is generally attributed to differences between the sexes with respect to prevalence of disease. However, when disease prevalence or Bayesian factors are 918 controlled, the predictive value of a positive test remains lower in women. 7 The reasons for this are unknown, as is the significance of the exercise electrocardiographic and ejection fraction findings. Obviously, caution must be used in ordering and interpreting diagnostic studies in a female patient when a false-positive result is as likely as a true-positive result or when the normal response is defined by reference values that do not apply to her.
Even the origins of cardiovascular disease may be different in men and women. Examination of risk factors for sudden, unexpected death in the Framingham Heart Study revealed that for men risk factors of coronary disease were also predictive of sudden death.8 This increases the plausibility of the accepted hypothesis that sudden death or fatal arrhythmias are related to atherosclerosis. However, in women, the coronary artery disease risk factors of systolic blood pressure, obesity, and smoking history were unrelated to sudden death, while hematocrit and vital capacity were found to be significant predictors. These findings have two important implications. First, from a pragmatic viewpoint, preventive health measures designed to reduce sudden death in one sex may afford little benefit to the other. Second, and perhaps more important, the discordance between male and female risk factors suggests that the hypothesized relationship between atherosclerosis and sudden death may be an incomplete reflection of the cause of sudden death. Thus, our understanding of the pathophysiology of this syndrome remains limited and further investigations are needed.
In contrast to most cardiovascular diseases, MVP is approximately eight times more common in women than in men. While it is generally a benign syndrome, a small subset of patients do develop severe mitral regurgitation requiring valve replacement. Several studies have sought to identify those at higher risk, examining such factors as left ventricular size, degree of prolapse, mitral leaflet thickening, left ventricular function, cardiomegaly on chest x-ray, and so on. One factor that has not been carefully considered is gender. Indeed, in a study recently published in the New England Journal of Medicine,9 the authors failed to consider the patients' sex as a descriptor despite noting that 16 of 17 of those requiring mitral valve replacement and four of six of those with sudden death were male in a population consisting of 142 women and 96 men. Similar results are suggested by Waller et al., 1' who found that nearly half (48%) of those requiring valve replacement for MVP were male, implying that progression to severe mitral regurgitation is far more common in men CIRCULATION with MVP than in women. The implications for clinical practice are clear: the diagnosis of MVP carries a graver prognosis in men and, once identified in a male patient, requires more careful medical follow-up. This may have economic impact as well, by affecting insurance underwriters' approach to patients with MVP. While the basis for the gender-related differences is unclear, further investigation of the unequal complication rate could conceivably elucidate something of the physiology of this disorder.
From these few examples, it is obvious that in today's practice of cardiology the same quality and quantity of data are not available for clinical decision making in patients of both sexes. The differences between the male and female responses, at least in some situations, render inaccurate the assumption that published results are applicable to all individuals. Without access to a detailed appreciation of what is truly healthy for a given individual, or what factors are associated with disease, the quality of care delivered is obviously limited. The importance of these issues was underscored by a National Heart, Lung, and Blood Institute workshop held in January 1986 addressing epidemiologic, pathophysiologic, and clinical aspects of ischemic heart disease in women." From a scientific viewpoint, investigation of the differences between the sexes may provide important clues to a better understanding of the physiology underlying our practice of medicine. These problems may be addressed immediately and relatively easily by reanalysis of preexisting data banks for consideration of gender as an important descriptor of outcome. If we fail to look for genderrelated differences or fail to investigate their significance, we not only do many of our patients an immedi-Vol. 74, No. 5, November 1986 ate disservice, but we also limit our ultimate understanding of the human organism.
